SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030122
Filing Date
2019-08-07
Accepted
2019-08-07 16:30:59
Documents
77
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 Q2 2019 10-Q ptla-10q_20190630.htm   iXBRL 10-Q 3205372
2 EX-10.5 ptla-ex105_69.htm EX-10.5 19162
3 EX-10.51 ptla-ex1051_19.htm EX-10.51 57288
4 EX-31.1 ptla-ex311_11.htm EX-31.1 9931
5 EX-31.2 ptla-ex312_8.htm EX-31.2 9952
6 EX-32.1 ptla-ex321_7.htm EX-32.1 9404
  Complete submission text file 0001564590-19-030122.txt   11218300

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ptla-20190630.xsd EX-101.SCH 69758
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptla-20190630_cal.xml EX-101.CAL 69259
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptla-20190630_def.xml EX-101.DEF 270356
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20190630_lab.xml EX-101.LAB 520852
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20190630_pre.xml EX-101.PRE 435486
12 EXTRACTED XBRL INSTANCE DOCUMENT ptla-10q_20190630_htm.xml XML 2333163
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35935 | Film No.: 191005913
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences